Clarus Therapeutics to Report Third Quarter 2021 Financial and Operating Results

Rhea-AI Summary

Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT) announced it will release its third quarter 2021 financial and operating results on November 18, 2021, after market close. A conference call will follow at 5:15 p.m. ET to discuss these results. Domestic callers can dial (844) 249-2007, while international callers should use (224) 619-3902; the conference ID is 1354439. The call will also be available as a live webcast on the company's Investors section.

NORTHBROOK, Ill., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced it will release its third quarter 2021 financial and operating results on Thursday, November 18, 2021, after the market closes.

Clarus will host a conference call on Thursday, November 18, 2021, at 5:15 p.m. ET to discuss the results. The dial-in numbers are (844) 249-2007 for domestic callers and (224) 619-3902 for international callers. The conference ID number is 1354439. A live webcast and replay of the conference call will be accessible through the Investors section of Clarus Therapeutics’ website at Investors.ClarusTherapeutics.com.

About Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women – including potential therapies for orphan indications. Clarus Therapeutics’ first commercial product is JATENZO® (testosterone undecanoate). For more information, visit www.clarustherapeutics.com and www.jatenzo.com. Follow us on Twitter (@Clarus_Thera) and LinkedIn (Clarus Therapeutics).

Clarus Investor Relations Contact:
Kara Stancell
kstancell@clarustherapeutics.com
(847) 562-4300 x 206

FAQ

When will Clarus Therapeutics release its third quarter financial results for 2021?

Clarus Therapeutics will release its third quarter 2021 financial results on November 18, 2021, after market close.

What time is the conference call for Clarus Therapeutics' Q3 results?

The conference call to discuss Clarus Therapeutics' Q3 results is scheduled for 5:15 p.m. ET on November 18, 2021.

What are the dial-in numbers for the Clarus Therapeutics conference call?

Domestic callers can reach the conference call at (844) 249-2007, while international callers should dial (224) 619-3902.

Where can I access the webcast of the Clarus Therapeutics conference call?

The live webcast and replay of the Clarus Therapeutics conference call can be accessed through the Investors section of their website.

What is the stock symbol for Clarus Therapeutics?

The stock symbol for Clarus Therapeutics is CRXT, and the warrants are listed under CRXTW.